Thanks for this response. It is a nice contrast to have someone post an accurate reading of the data presented and have an understanding of how trial protocols actually work.
Thanks for digging into results KMBJN. I'm not surprised to see that the placebo group accounts for the majority of dropouts. Placebo arm folks getting worse can't even swish and spit so giving up is very understandable.
The "market" and traders may be yawning, but as others have noted, any improvement / prevention of severe OM is very meaningful for patients going through this very difficult and painful treatment and disease.
If it helps patients, it will be a winner in the marketplace of effective and safe medical treatments.